A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression
Titel:
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression
Auteur:
Chouinard, G. Saxena, B.M. Nair, N.P.V. Kutcher, S.P. Bakish, D. Bradwejn, J. Kennedy, S.H. Sharma, V. Remick, R.A. Kukha-Mohamad, S.A. Belanger, M.C. Snaith, J. Beauclair, L. H., Pohlmann D'Souza, J.